Recipharm Ups Inhalation Capacity with $60M Sanofi U.K. Plant Buy
Attachment: farma
Recipharm has paid $60 million to acquire Sanofi's inhalation therapies contract manufacturing plant in Haverhill, U.K. The new site will complement the company's existing inhalation plant in Research Triangle Park (RTP), North Carolina. Industrial Info's Pharmaceutical & Biotech Business Intelligence Platform has detailed plant reports on 22 Recipharm facilities across the globe.
